The Atypical Chemokine Receptor 3 Market size is expected to grow at an annual average of cagr 5% during 2022-2028. Atypical chemokine receptor 3 (ACKR3) binds to the chemokines CXCL11 and CXCL12 and does not activate canonical G-protein signaling and communicates only through the -arrestin-mediated pathway. Because this receptor is upregulated in many cancers, it […]
